MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2019 International Congress

    Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

    M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)

    Objective: To study the effect of SLC6A3VNTR on PD patients’ cognition longitudinally. Background: Solute carrier family 6 neurotransmitter transporter dopamine member 3gene (SLC6A3) has two common…
  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2019 International Congress

    The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease

    G. Brandt, C. Palmisano, J. Brumberg, N. Pozzi, A. Canessa, G. Pezzoli, I. Isaias, J. Volkmann (Würzburg, Germany)

    Objective: To establish the contribution of striatal dopamine to gait initiation in Parkinson’s disease. Background: Gait initiation (GI) is characterized by anticipatory postural adjustments (APAs),…
  • 2019 International Congress

    Memory enhancing effect of Combined Alcoholic Extract of Cedrus deodara Loud. and Vitex Nirgundi in scopolamine-induced cognitive impairment in mice

    A. Jain, S. Jain (Sagar, India)

    Objective: Epidemiological studies of Indian population reveal that dementia is largely a hidden problem in India. Ayurveda claims several plants are beneficial in cognitive disorders.…
  • 2019 International Congress

    Tissue Engineered Nigrostriatal Pathway as an Anatomically-Inspired Test-Bed for Evaluating Axonal Pathophysiology

    E. Clark, L. Struzyna, W. Gordian-Velez, I. Chen, J. Duda, D.K. Cullen (Philadelphia, PA, USA)

    Objective: We previously developed the first micro-tissue engineered nigrostriatal pathway encased in a tubular hydrogel with 3D structure, multicellular composition, and architecture of long axonal…
  • 2019 International Congress

    Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: This study presents a novel method of predicting the behavioral pattern in male Sprague-Dawley rats with motor deficits impairment, based on the measurement of…
  • 2019 International Congress

    Glabellar tap predicts dopamine transporter deficiency in parkinsonism

    S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Mäkinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to investigate the association between glabellar tap findings with nigrostriatal dopamine function in patients with unclear parkinsonism. Background:…
  • 2019 International Congress

    Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

    Objective: To compare single-photon emission computed tomography (SPECT) with [123I]FP-CIT and positron emission tomography (PET) with [11C]PE2I as markers of dopamine transporter (DAT) loss in…
  • 2019 International Congress

    Awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease – Insights from an Indian Parkinson’s Registry

    N. Sawal, K. Shukla (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. Study evaluated how many patient were spacing  levodopa correctly, its effect on…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 27
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley